Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World

NCT02964091 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: sofosbuvir/ledipasvir

Sponsor

Partners in Health